Charge of the Committee
The Committee shall convene at least two (2) times per year to advise the Director:
(a) On the implementation and evaluation of the Program;
(b) On the establishment of criteria for indicators of possible misuse or abuse of covered substances;
(c) On standardization of the methodology that should be used for analysis and interpretation of prescription monitoring data;
(d) In determining the most efficient and effective manner in which to disclose the findings to proactively inform prescribers regarding the indications of possible abuse or misuse of covered substances;
(e) On identifying drugs of concern that demonstrate a potential for abuse and that should be monitored; and
(f) Regarding the design and implementation of educational courses for:
(1) Persons who are authorized to access the prescription monitoring information;
(2) Persons who are authorized to access the prescription monitoring information, but who have violated the laws or breached professional standards involving the prescribing, dispensing, or use of any controlled substances or drugs monitored by the Program;
(3) Prescribers on prescribing practices, pharmacology, and identifying, treating, and referring patients addicted to or abusing controlled substances or drugs monitored by the Program; and
(4) The public about the use, diversion and abuse of, addiction to, and treatment for the addiction to controlled substances or drugs monitored by the Program.
Advisory Committee Members
Jacqueline Watson, DO, MBA, DC Health Chief of Staff
Justin Ortique, PharmD, RPh, CPM, Board of Pharmacy Executive Director
Aisha Nixon, MPT, CPM, Board of Medicine Executive Director
Natalie Kirilichin, MD, MPH, Emergency Medicine Physician
Sheri Doyle, MPH, Consumer Member
Captain Shawn Rooney, Metropolitan Police Department
Lakisha Stiles, CPhT, Pharmacy Technician